KIROVYZE
Live / Applied — Fifth extension granted (statement of use) (as of 23 Jun 2026)
What this means for you
Not registered yet, but its 12 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97714234
- Mark type
- Stylized text
- Filed
- 12 Dec 2022
- Published for opposition
- 24 Oct 2023
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders
Owner
- Bridgebio Pharma, Inc., Palo Alto, CA, US
- Bridgebio Pharma, Inc., Palo Alto, CA, US
Prosecution history
- 24 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2026 — SOU EXTENSION 5 GRANTED
- 17 Jun 2026 — SOU EXTENSION 5 FILED
- 18 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Nov 2025 — SOU EXTENSION 4 GRANTED
- 11 Nov 2025 — SOU EXTENSION 4 FILED
- 11 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 22 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 May 2025 — SOU EXTENSION 3 GRANTED
- 21 May 2025 — SOU EXTENSION 3 FILED
- 21 May 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2024 — SOU EXTENSION 2 GRANTED
- 08 Nov 2024 — SOU EXTENSION 2 FILED